Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mohammed Nabil Nabil Quraishi (Mohammed Nabil Quraishi, M N Quraishi)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

Frontline gastroenterology

Alimentary pharmacology & therapeutics

BMJ open

Clinical and experimental immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Nabil Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, Shahida Din, Ruth Wakeman, J R Fraser Cummings, Shaji Sebastian, Stuart Bloom, Jimmy K Limdi, Anjan Dhar, R Alexander Speight, Keith Bodger, Nicholas A Kennedy, null null, Christopher Andrew Lamb, Ian D Arnott, Christian P Selinger
Establishing key performance indicators for inflammatory bowel disease in the UK. Frontline gastroenterology 14 (5) (2023)
Shafquat Zaman, Akinfemi Akingboye, Ali Yasen Y Mohamedahmed, Elizabeth Peterknecht, Pratik Bhattacharya, Mohammed E El-Asrag, Tariq H Iqbal, Mohammed Nabil Nabil Quraishi, Andrew D Beggs
Faecal microbiota transplantation (FMT) in the treatment of chronic refractory pouchitis: A systematic review and meta-analysis. Journal of Crohn's & colitis (2023)
Aditi Kumar, Mohammed Nabil Nabil Quraishi, Shanika de Silva, Nigel John Trudgill, Helen Steed, Matthew James Brookes, Rachel Cooney
Insight from patients and healthcare professionals on the implementation of virtual clinics in patients with inflammatory bowel disease. Frontline gastroenterology 13 (2) (2021)
Gianluca G Ianiro, Benjamin Harvey Mullish, Colleen R Kelly, Zain Kassam, Ed J Kuijper, William K K Wu, Tariq H Iqbal, Jessica R Allegretti, Stefano Bibbò, Harry Sokol, Faming Zhang, Monika Fischer, Samuel Paul Costello, Josbert J Keller, Luca Masucci, Joffrey van Prehn, Gianluca Quaranta, Mohammed Nabil Nabil Quraishi, Jonathan P Segal, Dina Kao, Reetta Satokari, Maurizio Sanguinetti, Herbert Tilg, Antonio Gasbarrini, Giovanni Cammarota
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 69 (9) (2020)
Mohammed Nabil Nabil Quraishi, Rachel Cooney, Matthew James Brookes, Naveen Sharma
An urgent need to institute COVID-19 testing in patients with IBD experiencing flares. Frontline gastroenterology 11 (4) (2020)
Nasir Mir, Jonathan Cheesbrough, Thomas Troth, Nasir Hussain, Laurence Joseph Hopkins, Jiaqi Shi, Najiat Sarker, Emma Smith, Finula Courtney, Jill Flaherty, Rebecca Hill, Sarah Jebb, Villa Kakosa, Jason Calderwood, Naveen Sharma, Adam McCulloch, Mohammed Nabil Nabil Quraishi
COVID-19-related health anxieties and impact of specific interventions in patients with inflammatory bowel disease in the UK. Frontline gastroenterology 12 (3) (2020)
Jonathan P Segal, Benjamin Harvey Mullish, Mohammed Nabil Nabil Quraishi, Tariq H Iqbal
Letter: faecal microbiota transplantation for IBS. Alimentary pharmacology & therapeutics 52 (3) (2020)
Mohammed Nabil Nabil Quraishi, Walaa A Shaheen
Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Alimentary pharmacology & therapeutics 50 (5) (2020)
Mohammed Nabil Nabil Quraishi, Mehmet Yalchin, Clare Blackwell, Jonathan Segal, Naveen Sharma, Peter Hawkey, Victoria McCune, Ailsa L Hart, Daniel Gaya, Natalie J Ives, Laura Magill, Shrushma Loi, Catherine Hewitt, Konstantinos Gerasimidis, Nicholas James Loman, Richard Hansen, Christel M McMullan, Jonathan Mathers, Christopher Quince, Nicola Crees, Tariq Iqbal
STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ open 9 (11) (2019)
Mehmet Yalchin, Jonathan P Segal, Benjamin Harvey Mullish, Mohammed Nabil Nabil Quraishi, Tariq H Iqbal, Julian R Marchesi, Ailsa L Hart
Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease. Therapeutic advances in gastroenterology 12 (2019)
Mohammed Nabil Nabil Quraishi, W Shaheen, Y H Oo, Tariq H Iqbal
Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease. Clinical and experimental immunology 199 (1) (2019)
Mohammed Nabil Nabil Quraishi, M Widlak, N Bhala, D Moore, M Price, N Sharma, T H Iqbal
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Alimentary pharmacology & therapeutics 46 (5) (2017)

Mohammed Nabil Nabil Quraishi.css-eqlu8i{font-size:small;padding-left:4px;} (Mohammed Nabil Quraishi, M N Quraishi)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammed Nabil Nabil Quraishi (Mohammed Nabil Quraishi, M N Quraishi)